Lynch, Thomas James
- Fred Hutchinson Cancer Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #212
- Sustained Excellence
- Program Leader
- Top 5% Funded
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$10.6M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#212
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Lynch, Thomas James as a PI. Multi-PI records show the full award amount for context.
- $10.1Maward amount
- 3P30CA015704-48S3P30Contact PICCSG Supplement: To Strengthen the Research, Training, and Outreach Capacity$199.7Kaward amount
- $194.4Kaward amount
- 3P30CA015704-48S2P30Contact PICCSG Supplement: ATR Inhibition in Advanced PD(L)1-Refractory Merkel Cell Carcinoma$125Kaward amount
Award organization
Organizations that administered FY2023 awards listing Lynch, Thomas James as a PI.
FY2023 award administered by Fred Hutchinson Cancer Center (WA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardFred Hutchinson Cancer Center
- 2009$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2009Entered Top 50% NationallyRanked #3570
- 2009Entered Top 25% NationallyRanked #3570
- 2010$2M Cumulative Funding
- 2011$5M Cumulative Funding
- 2013Entered Top 10% NationallyRanked #1722
- 2014$10M Cumulative Funding
- 2014Program/Center Grant Leader
- 2020Entered Top 5% NationallyRanked #52
- 2020Entered Top 1% NationallyRanked #52
- 2021$25M Cumulative Funding
- 2023$50M Cumulative Funding